MASM
BIIB icon

MH & Associates Securities Management’s Biogen BIIB Stock Holding History

MH & Associates Securities Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82M Sell
17,659
-58
-0.3% -$11.1K 3.42% 4
2026
Q1 		$3.25M Buy
17,717
+119
+0.7% +$21.9K 2.83% 14
2025
Q4 		$3.1M Buy
+17,598
New +$2.88M 2.53% 18

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MH & Associates Securities Management's BIIB Position: Q2 2026 in Review

MH & Associates Securities Management reduced its Biogen (BIIB) stake by 0.33% in Q2 2026, selling an estimated $11.1K and leaving 17,659 shares worth $3.82M. The position accounts for 3.42% of the portfolio, ranked #4.

MH & Associates Securities Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 651 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • MH & Associates Securities Management held 17,659 shares of Biogen worth $3.82M as of Q2 2026.
  • MH & Associates Securities Management sold 58 Biogen shares in Q2 2026, an estimated $11.1K.
  • Biogen made up 3.42% of MH & Associates Securities Management's portfolio in Q2 2026, its #4 holding.
  • MH & Associates Securities Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 651 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on MH & Associates Securities Management's 13F filing for Q2 2026, filed 28 Jul 2026.